3647 results for «590»

Filter By

3647 results

EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony

19 May 2017 – From EuroPCR 2017

Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.

EuroPCR 2017 Closing Ceremony

19 May 2017 – From EuroPCR 2017

EuroPCR 2017 Closing

GulfPCR-GIM 2017 Opening Ceremony

13 Dec 2017 – From GulfPCR-GIM 2017

Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...

GulfPCR-GIM 2017 Opening Ceremony

GulfPCR-GIM 2017 Award and Closing Ceremony

14 Dec 2017 – From GulfPCR-GIM 2017

Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.

GulfPCR-GIM 2017: Award and Closing Ceremony

Top Interventional Trials presented at ACC.21

07 Jun 2021

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Ali Nazmi Calik

Author

Ali Nazmi Calik
Top Interventional Trials presented at ACC.21

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Dr. F. Alfonso

Author

Fernando Alfonso
Javier Cuesta

Author

Javier Cuesta
Future directions of drug-coated balloon angioplasty
Didn’t find what you were looking for?